The use of tALP and BSAP together has beenconsidered the gold standard, especially for the study of new potential biomarkersfor prognostic evaluation in patients with prostate cancer, such as P1NP, which is ametabolite directly associated with bone formation(23). Here, PAX5 is linked to prostate carcinoma.